Moreover, a subsequent study revealed that WT1-AS expression can be used as an independent predictor of ccRCC prognosis and that patients with high WT1-AS expression had poorer prognosis (24). This evidence concerns the gene WT1 and nonpapillary renal cell carcinoma.